These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3713942)

  • 1. Enhanced in vitro platelet aggregation in hemodialysis patients.
    Viener A; Aviram M; Better OS; Brook JG
    Nephron; 1986; 43(2):139-43. PubMed ID: 3713942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced platelet aggregation in chronic renal failure patients receiving hemodialysis treatment.
    Bemis J; Rigney J; Sosin A; Deane N
    Trans Am Soc Artif Intern Organs; 1977; 23():48-53. PubMed ID: 910370
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombocyte aggregation during adequate periodic hemodialysis].
    Kiriakov Z; Deliĭski M; Kamenov V; Ionova D
    Khirurgiia (Sofiia); 1985; 38(5):8-11. PubMed ID: 4087773
    [No Abstract]   [Full Text] [Related]  

  • 4. Is heparin responsible for enhanced platelet aggregation after haemodialysis?
    Charvát J; König J; Bláha J
    Nephron; 1986; 44(2):89-91. PubMed ID: 3774081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk.
    Aggarwal A; Kabbani SS; Rimmer JM; Gennari FJ; Taatjes DJ; Sobel BE; Schneider DJ
    Am J Kidney Dis; 2002 Aug; 40(2):315-22. PubMed ID: 12148104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of azathioprine and mizoribine on aggregation of normal and uremic platelets.
    Malyszko JS; Malyszko J; Pawlak K; Mysliwiec M; Takada Y; Takada A
    Transplant Proc; 1996 Dec; 28(6):3488-9. PubMed ID: 8962356
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of ultrafiltrates in plasma from patients with chronic uremia on platelet aggregation].
    Myśliwiec M; Popławski A; Soszka J
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):76-8. PubMed ID: 1845699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1 potentiates ADP-induced platelet aggregation in chronic renal failure.
    Heintz B; Schmidt P; Maurin N; Kirsten R; Nelson K; Wieland D; Sieberth HG
    Ren Fail; 1994; 16(4):481-9. PubMed ID: 7938756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbacyclin derivative (CS-570). A new anticoagulant for hemodialysis.
    Suzuki T; Naganuma S; Takahashi K; Ota K
    ASAIO Trans; 1986; 32(1):291-6. PubMed ID: 3535844
    [No Abstract]   [Full Text] [Related]  

  • 10. "In vitro" inhibition of platelet aggregation by uremic middle molecules.
    Gallice P; Fournier N; Crevat A; Saingra S; Frayssinet R; Murisasco A; Sicardi F
    Biomedicine; 1980; 33(6):185-8. PubMed ID: 7213919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of platelet function by increased frequency of hemodialysis.
    Lindsay RM; Friesen M; Aronstam A; Andrus F; Clark WF; Linton AL
    Clin Nephrol; 1978 Aug; 10(2):67-70. PubMed ID: 699401
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of peritoneal dialysis, haemodialysis and kidney transplantation on blood platelet function. I. Platelet aggregation by ADP and epinephrine.
    Nenci GG; Berrettini M; Agnelli G; Parise P; Buoncristiani U; Ballatori E
    Nephron; 1979; 23(6):287-92. PubMed ID: 384281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diclofenac sodium (feloran) on platelet aggregation.
    Tyutyulkova N; Gorantcheva Y; Lisitchkov T
    Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):21-5. PubMed ID: 6717167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis.
    Sirolli V; Strizzi L; Di Stante S; Robuffo I; Procopio A; Bonomini M
    Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of in vitro closure time test for evaluating platelet-related primary hemostasis in dialysis patients.
    Zupan IP; Sabovic M; Salobir B; Ponikvar JB; Cernelc P
    Am J Kidney Dis; 2003 Oct; 42(4):746-51. PubMed ID: 14520625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased platelet aggregation in psoriasis.
    Hayashi S; Shimizu I; Miyauchi H; Watanabe S
    Acta Derm Venereol; 1985; 65(3):258-62. PubMed ID: 2411087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation in patients with peripheral vascular disease.
    Ward AS; Porter N; Preston FE; Morris-Jones W
    Atherosclerosis; 1978 Jan; 29(1):63-8. PubMed ID: 629826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Potentiating effect of some fatty acids on platelet aggregation induced with ADP, collagen and 1-epinephrine].
    Musso R; Russo M; Raimondo V
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):569-75. PubMed ID: 7378191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily variations in platelet aggregation and adhesion in healthy subjects.
    Fujimura A; Ohashi K; Ebihara A
    Life Sci; 1992; 50(14):1043-7. PubMed ID: 1552822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of latamoxef on platelet aggregation in hemodialysis and continuous ambulatory peritoneal dialysis (CAPD) patients].
    Inoue T; Sakaguchi K; Yoshida K; Imai T; Kajimoto Y; Shirai D
    Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):177-83. PubMed ID: 3735768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.